Update on cell therapy for stroke. Issue 2 (22nd May 2017)

• Record Type: Journal Article
• Authors: Kenmuir, Cynthia L; Wechsler, Lawrence R
• Is Part Of: Stroke and vascular neurology. Volume 2:Issue 2(2017)
• Page Start: 59
• Page End: 64
• Publication Date: 2017-05-22
• Subjects: stroke -- cell therapy -- stem cell; Cerebrovascular disease -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; 616.81005
• DOI: 10.1136/svn-2017-000070
• Languages: English
• ISSNs: 2059-8688

Abstract

Abstract : Ischaemic stroke remains a leading cause of death and disability. Current stroke treatment options aim to minimise the damage from a pending stroke during the acute stroke period using intravenous thrombolytics and endovascular thrombectomy; however, there are no currently approved treatment options for reversing neurological damage once a stroke is completed. Preclinical studies suggest that cell therapy may be safe and effective in improving functional outcomes. Several recent clinical trials have reported safety and some improvement in outcomes following cell therapy administration in ischaemic stroke, which are reviewed. Cell therapy may provide a promising new treatment for stroke reducing stroke-related disability. Further investigation is needed to determine specific effects of cell therapy and to optimise cell delivery methods, cell dosing, type of cells used, timing of delivery, infarct size and location of infarct that are likely to benefit from cell therapy.